Join
Login
Join
Login
"Where Everyone Has an MBA"
Tel: (612) 246-4616
Home
Financial Analysis
Companies
Industries
Glossary
About
Frequently Asked Questions
User Testimonials
Contact Us
Navigation
Home
Financial Analysis
Companies
Industries
Glossary
About
- Frequently Asked Questions
- User Testimonials
Contact Us
Annexon, Inc. - SIC # 2830 -
Ticker
Exchange
SIC #
Website
Latest Ticker
ANNX
Nasdaq
2830
www.annexonbio.com
Select one of the four (4) financial statement analysis reports below to view the ratio analysis report for your selected company:
Latest Headlines for Annexon, Inc.
Annexon Reports Inducement Grants to New Employees Under Nasdaq Listing Rule 5635(c)(4)
- Jun 16th, 2026 2:05 pm
Annexon Eyes ‘Win Season’ With Q4 Vision Trial Data, GBS Filings Ahead
- Jun 9th, 2026 7:06 am
Exploring 3 High Growth Tech Stocks in the US Market
- Jun 9th, 2026 5:38 am
Annexon Maps 3 Big Pipeline Catalysts Ahead of Q4 Vision-Drug Readout
- Jun 4th, 2026 1:07 am
Annexon to Participate in Upcoming June Investor Conferences
- May 27th, 2026 6:00 am
Annexon Highlights Q4 Geographic Atrophy Data, GBS Filing Plans at BofA Conference
- May 14th, 2026 2:05 am
110 Years. 110 Stories. 110 Reasons to Raise Awareness for GBS
- May 11th, 2026 8:00 am
Annexon Reports First Quarter 2026 Financial Results, Portfolio Progress and Key Anticipated Milestones
- May 7th, 2026 2:01 pm
Annexon to Present at the Bank of America Securities Health Care Conference 2026
- May 6th, 2026 6:00 am
Annexon (ANNX): 7 Small Cap Stocks with the Highest Upside Potential
- Apr 27th, 2026 12:22 am
Annexon Biosciences (ANNX) Buy Rating Retained
- Apr 21st, 2026 3:14 pm
Annexon CEO Touts “Win Year” 2026 at Needham, Eyes GA Phase III Data and GBS FDA Filing
- Apr 15th, 2026 3:02 pm
Annexon to Present at the 25th Annual Needham Virtual Healthcare Conference
- Apr 8th, 2026 2:05 pm
Wall Street Analysts See a 165.52% Upside in Annexon (ANNX): Can the Stock Really Move This High?
- Apr 1st, 2026 7:55 am
Is Annexon (NASDAQ:ANNX) In A Good Position To Deliver On Growth Plans?
- Apr 1st, 2026 4:59 am
Annexon Reports Fourth Quarter and Year-End 2025 Financial Results, Portfolio Progress and Key Anticipated Milestones
- Mar 30th, 2026 2:01 pm
Are Medical Stocks Lagging American Well (AMWL) This Year?
- Mar 23rd, 2026 7:40 am
Annexon Investor Day: ANX007 Targets C1q in Dry AMD GA as Phase III Readout Nears Q4
- Mar 18th, 2026 8:02 pm
Annexon Reports Inducement Grant to New Employee Under Nasdaq Listing Rule 5635(c)(4)
- Mar 16th, 2026 2:05 pm
Annexon Spotlights GA Phase III, GBS Regulatory Plans and ANX1502 Update at TD Cowen Conference
- Mar 4th, 2026 3:48 am
Scroll